August 23, 2023. Saratoga Capital is pleased to announce its strategic investment in Orange Nebula, a healthcare technology company focused on modernising pharmacy access through an innovative digital platform that connects healthcare providers, patients, and pharmacy services.
The investment supports Orange Nebula’s continued expansion of its technology-enabled healthcare ecosystem, designed to improve patient outcomes by streamlining prescription fulfilment and enhancing the efficiency of post-consultation care.
Investment Overview
Orange Nebula has developed a proprietary healthcare platform that enables patients to receive prescribed medication within 48 hours following consultation with participating medical professionals. Through its QR code-enabled workflow, the platform simplifies prescription management while improving communication between healthcare providers and pharmacy partners.
The company’s business model is centred on strategic partnerships with chiropractic clinics and other healthcare providers, offering integrated pharmacy solutions that enhance patient access to medication while creating operational efficiencies for medical practices.
Led by Dr. Ali Rafie, a healthcare professional with more than three decades of clinical experience, Orange Nebula combines healthcare expertise with digital innovation to address inefficiencies in prescription fulfilment, particularly within the personal injury and workers’ compensation sectors.
Investment Thesis
Saratoga Capital identified Orange Nebula as an attractive investment opportunity supported by several long-term industry trends:
- Proprietary healthcare technology addressing inefficiencies in pharmacy access.
- Scalable B2B platform serving healthcare providers and pharmacy partners.
- Experienced management team with deep clinical and industry expertise.
- Exposure to the growing digital healthcare and pharmacy technology sectors.
- Increasing adoption of technology-enabled healthcare delivery and telemedicine.
- Strong structural demand driven by an ageing population, rising prevalence of chronic disease, and continued growth in specialty pharmaceutical services.
Value Creation Strategy
Saratoga Capital’s investment is intended to accelerate Orange Nebula’s next phase of growth through strategic capital investment and operational support.
Key initiatives include:
- Expanding the company’s network of healthcare provider partnerships.
- Scaling the proprietary technology platform across additional markets.
- Enhancing product functionality and user experience through continued technology investment.
- Strengthening commercial operations and strategic business development.
- Pursuing strategic partnerships within the broader healthcare ecosystem.
- Supporting regulatory compliance, governance, and operational infrastructure required for long-term growth.
Long-Term Vision
Orange Nebula represents Saratoga Capital’s commitment to investing in innovative healthcare businesses that leverage technology to improve patient outcomes while delivering scalable, sustainable business models.
By combining clinical expertise with digital innovation, the company is well positioned to become a leading provider of technology-enabled pharmacy solutions, supporting healthcare professionals, improving access to medication, and creating long-term value for patients, providers, and investors alike.
About Saratoga Capital
Founded in 2008, Saratoga Capital Partners is a private equity and alternative asset management group with a strong foundation in advisory and capital markets. Building on this heritage, the firm now focuses on private equity and alternative investments, partnering with investors and portfolio companies to drive growth, unlock long-term value, and deliver attractive returns.